ID: ALA5278566

Max Phase: Preclinical

Molecular Formula: C24H38N6O9

Molecular Weight: 554.60

Associated Items:

Representations

Canonical SMILES:  CCCCCCCn1cc(C[C@H](O[C@@H]2O[C@H](CN)[C@@H](O)[C@H]2O)[C@H]2O[C@@H](n3ccc(=O)[nH]c3=O)[C@H](O)[C@@H]2O)nn1

Standard InChI:  InChI=1S/C24H38N6O9/c1-2-3-4-5-6-8-29-12-13(27-28-29)10-14(37-23-20(35)17(32)15(11-25)38-23)21-18(33)19(34)22(39-21)30-9-7-16(31)26-24(30)36/h7,9,12,14-15,17-23,32-35H,2-6,8,10-11,25H2,1H3,(H,26,31,36)/t14-,15+,17+,18-,19+,20+,21+,22+,23+/m0/s1

Standard InChI Key:  BDXVKABRRVJCRS-KQXJDBLFSA-N

Associated Targets(non-human)

Cutaneotrichosporon cutaneum 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Candida albicans 78123 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus chromogenes 18 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Phospho-N-acetylmuramoyl-pentapeptide-transferase 27 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 554.60Molecular Weight (Monoisotopic): 554.2700AlogP: -2.25#Rotatable Bonds: 13
Polar Surface Area: 220.20Molecular Species: BASEHBA: 14HBD: 6
#RO5 Violations: 3HBA (Lipinski): 15HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 9.70CX Basic pKa: 8.75CX LogP: -1.14CX LogD: -2.26
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.14Np Likeness Score: 0.54

References

1. Serpi M, Ferrari V, Pertusati F..  (2016)  Nucleoside Derived Antibiotics to Fight Microbial Drug Resistance: New Utilities for an Established Class of Drugs?,  59  (23): [PMID:27607900] [10.1021/acs.jmedchem.6b00325]

Source